Impax Asset Management Group
ELV icon

Impax Asset Management Group’s Elevance Health ELV Stock Holding History

Impax Asset Management Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
34,127
+3,880
+13% +$1.44M 0.09% 154
2026
Q1 		$8.85M Buy
30,247
+2,404
+9% +$790K 0.06% 166
2025
Q4 		$9.76M Sell
27,843
-451
-2% -$152K 0.06% 152
2025
Q3 		$9.14M Buy
28,294
+764
+3% +$238K 0.05% 152
2025
Q2 		$10.7M Sell
27,530
-1,140
-4% -$459K 0.06% 135
2025
Q1 		$12.5M Buy
28,670
+3,074
+12% +$1.23M 0.08% 130
2024
Q4 		$9.44M Buy
25,596
+291
+1% +$122K 0.04% 166
2024
Q3 		$13.2M Buy
25,305
+1,435
+6% +$767K 0.05% 141
2024
Q2 		$12.9M Sell
23,870
-764
-3% -$404K 0.05% 143
2024
Q1 		$12.8M Sell
24,634
-1,616
-6% -$804K 0.05% 151
2023
Q4 		$12.4M Sell
26,250
-1,437
-5% -$664K 0.05% 161
2023
Q3 		$12.1M Sell
27,687
-18
-0.1% -$8.16K 0.05% 145
2023
Q2 		$12.3M Sell
27,705
-1,779
-6% -$821K 0.05% 150
2023
Q1 		$13.6M Sell
29,484
-99
-0.3% -$47.1K 0.06% 140
2022
Q4 		$15.2M Sell
29,583
-1,225
-4% -$622K 0.07% 129
2022
Q3 		$14M Buy
30,808
+10,253
+50% +$4.91M 0.07% 132
2022
Q2 		$9.92M Sell
20,555
-199
-1% -$98.4K 0.05% 148
2022
Q1 		$10.2M Buy
20,754
+20
+0.1% +$9.14K 0.04% 155
2021
Q4 		$9.61M Buy
20,734
+6
+0% +$2.52K 0.04% 172
2021
Q3 		$7.73M Sell
20,728
-1,148
-5% -$436K 0.03% 181
2021
Q2 		$8.35M Buy
21,876
+4,195
+24% +$1.6M 0.04% 173
2021
Q1 		$6.35M Buy
17,681
+3,028
+21% +$974K 0.03% 178
2020
Q4 		$4.71M Sell
14,653
-14
-0.1% -$4.3K 0.03% 173
2020
Q3 		$3.94M Buy
14,667
+3,078
+27% +$828K 0.03% 173
2020
Q2 		$3.05M Buy
11,589
+4,945
+74% +$1.32M 0.03% 182
2020
Q1 		$1.51M Buy
6,644
+1,047
+19% +$285K 0.02% 202
2019
Q4 		$1.69M Buy
5,597
+468
+9% +$129K 0.02% 201
2019
Q3 		$1.23M Buy
5,129
+509
+11% +$139K 0.02% 203
2019
Q2 		$1.3M Buy
4,620
+448
+11% +$122K 0.02% 194
2019
Q1 		$1.2M Buy
4,172
+699
+20% +$202K 0.02% 221
2018
Q4 		$912K Buy
+3,473
New +$955K 0.01% 210

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Impax Asset Management Group's ELV Position: Q2 2026 in Review

Impax Asset Management Group increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $1.44M and bringing the position to 34,127 shares worth $13.2M. The position accounts for 0.09% of the portfolio, ranked #154.

Impax Asset Management Group first reported a position in ELV in Q4 2018 and has held it in 31 quarters since. The position peaked at $15.2M in Q4 2022. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Impax Asset Management Group held 34,127 shares of Elevance Health worth $13.2M as of Q2 2026.
  • Impax Asset Management Group bought 3,880 Elevance Health shares in Q2 2026, an estimated $1.44M.
  • Elevance Health made up 0.09% of Impax Asset Management Group's portfolio in Q2 2026, its #154 holding.
  • Impax Asset Management Group first reported a position in Elevance Health in Q4 2018 and has held it in 31 quarters since.
  • Impax Asset Management Group's Elevance Health position peaked at $15.2M in Q4 2022.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.